RECRUITING Phase 3 ClinicalTrials.gov

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Sponsor: Sanofi • ClinicalTrials.gov ID: NCT07190222

Registry updated: 2026-10-01

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype. Participation to the study consists of 3 periods: * Screening period of up to 4 weeks * Randomized intervention period of approximately 48 weeks * Follow-up period: Approximately 8 weeks The study duration will be up to 60 weeks.

Interventions

Lunsekimig (Drug)
Pharmaceutical form: solution for injection in prefilled syringe. Route of administration: Subcutaneous injection
Placebo (Drug)
Pharmaceutical form: solution for injection. Route of administration: Subcutaneous injection

Eligibility criteria

Inclusion Criteria: * Between 40 to 80 years of age * Physician diagnosed chronic obstructive pulmonary disease (COPD) ≥1 year * Post-bronchodilator forced expiratory volume in 1 second (post-BD FEV1) ≥ 20% and ≤ 70% of predicted value and FEV1/FVC (forced expiratory volume in 1 second /forced vital capacity) \<0.70 * Former or current smokers ≥10 pack-years * Chronic Airways Assessment Test (CAAT) ≥10 * ≥2 moderate or ≥1 severe COPD exacerbations in the prior year * Triple (ICS+LABA+LAMA) COPD therapy ≥12 consecutive weeks * EOS (blood eosinophil count) ≥ 150 cells/μL * 18.0 ≤ Body Mass Index ≤ 40.0 kg/m2 Exclusion Criteria: Participants are excluded from the study if any of the following criteria apply: * Asthma, including pediatric asthma, or asthma-COPD overlap syndrome (ACOS) * Significant pulmonary disease other than COPD * Long-term oxygen therapy \>4.0 L/min or requirement of \>2.0 L/min to maintain oxygen saturation \>88% at rest * Unstable disorder that can impact participants safety or study outcomes * Active or incompletely treated tuberculosis * Current or past malignancies * Concomitant therapies: * long-term macrolides or phosphodiesterase Type 3 (PDE-3) or PDE-4 inhibitors unless on stable therapy for \> 6 months * any biologic therapy or systemic immunosuppressant within 4 months or 5 half-lives prior to Screening The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Conditions

Chronic Obstructive Pulmonary Disease

Locations

University of Alabama at Birmingham- Site Number : 8400003 — Birmingham, Alabama, United States
Pulmonary Associates - Mobile- Site Number : 8400151 — Mobile, Alabama, United States
Tucson Clinical Research Institute- Site Number : 8400006 — Tucson, Arizona, United States
Ark Clinical Research- Site Number : 8400113 — Long Beach, California, United States
Inglewood Clinical- Site Number : 8400074 — Los Angeles, California, United States
Alliance Clinical - West Hills- Site Number : 8400067 — Los Angeles, California, United States
California Medical Research Associates - Northridge- Site Number : 8400089 — Northridge, California, United States
Acclaim Clinical Research- Site Number : 8400068 — San Diego, California, United States
Alpine Clinical Research Center - Boulder - 47th Street- Site Number : 8400005 — Boulder, Colorado, United States
Critical Care Pulmonary & Sleep Associates- Site Number : 8400081 — Lakewood, Colorado, United States
Howard University Hospital- Site Number : 8400080 — Washington D.C., District of Columbia, United States
Meris Clinical Research- Site Number : 8400153 — Brandon, Florida, United States
Hillcrest Medical Research- Site Number : 8400082 — DeLand, Florida, United States
Finlay Medical Research - Greenacres- Site Number : 8400107 — Greenacres City, Florida, United States
Direct Helpers Research Center- Site Number : 8400057 — Hialeah, Florida, United States
University of Florida - Jacksonville- Site Number : 8400126 — Jacksonville, Florida, United States
Salud Clinical Services- Site Number : 8400109 — Lehigh Acres, Florida, United States
Pulmonary Specialists of the Palm Beaches- Site Number : 8400017 — Loxahatchee Groves, Florida, United States
Elite Clinical Research - Miami- Site Number : 8400167 — Miami, Florida, United States
DL Research Solutions- Site Number : 8400140 — Miami, Florida, United States
Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027 — Miami, Florida, United States
Professional Research Center- Site Number : 8400046 — Miami, Florida, United States
Research Institute of South Florida- Site Number : 8400028 — Miami, Florida, United States
Innovations Biotech- Site Number : 8400019 — Miami, Florida, United States
Heuer M.D. Research- Site Number : 8400018 — Orlando, Florida, United States
Florida Institute for Clinical Research- Site Number : 8400001 — Orlando, Florida, United States
Avanza Medical Research Center- Site Number : 8400015 — Pensacola, Florida, United States
Hull and Hull Medical Specialists- Site Number : 8400002 — Plantation, Florida, United States
Windom Allergy, Asthma and Sinus Specialists- Site Number : 8400041 — Sarasota, Florida, United States
Stat Care Pulmonary and Sleep- Site Number : 8400138 — St. Petersburg, Florida, United States
Better Life Clinical Research- Site Number : 8400152 — Tampa, Florida, United States
Vicis Clinical Research- Site Number : 8400158 — Tampa, Florida, United States
Appalachian Clinical Research- Site Number : 8400060 — Adairsville, Georgia, United States
Christie Clinic in Champaign on University- Site Number : 8400023 — Champaign, Illinois, United States
Sneeze Wheeze & Itch Associates- Site Number : 8400020 — Normal, Illinois, United States
Peoria Pulmonary Associates Ltd- Site Number : 8400095 — Peoria, Illinois, United States
Asha Clinical Research - Munster- Site Number : 8400115 — Hammond, Indiana, United States
Ochsner LSU Health Shreveport - Academic Medical Center- Site Number : 8400083 — Shreveport, Louisiana, United States
Care Access - Shreveport - Youree Drive- Site Number : 8400007 — Shreveport, Louisiana, United States
Johns Hopkins Bayview Medical Center- Site Number : 8400076 — Baltimore, Maryland, United States
Lucida Clinical Trials- Site Number : 8400101 — New Bedford, Massachusetts, United States
Vitalis Clinical Research Center- Site Number : 8400040 — Allen Park, Michigan, United States
Bolt Clinical Research- Site Number : 8400086 — Brighton, Michigan, United States
Henry Ford Hospital- Site Number : 8400058 — Detroit, Michigan, United States
Pulmonary Research Institute of Southeast Michigan - Farmington Hills- Site Number : 8400161 — Farmington Hills, Michigan, United States
University of Missouri Health Care - Children's Hospital- Site Number : 8400150 — Columbia, Missouri, United States
Hannibal Regional Healthcare System- Site Number : 8400035 — Hannibal, Missouri, United States
Washington University- Site Number : 8400144 — St Louis, Missouri, United States
Excel Clinical Research - Las Vegas- Site Number : 8400070 — Las Vegas, Nevada, United States
AB Clinical Trials- Site Number : 8400075 — Las Vegas, Nevada, United States
Bioluminux Clinical Research - Hamilton, New Jersey- Site Number : 8400037 — Hamilton, New Jersey, United States
Rutgers Institute For Infectious & Inflammatory Diseases (I3d)- Site Number : 8400093 — Newark, New Jersey, United States
Trinity Medical, WNY- Site Number : 8400157 — Buffalo, New York, United States
Mid Hudson Medical Research - New Windsor- Site Number : 8400004 — New Windsor, New York, United States
East Carolina University- Site Number : 8400102 — Greenville, North Carolina, United States
Piedmont Healthcare - Family Medicine- Site Number : 8400022 — Statesville, North Carolina, United States
All-Trials Clinical Research- Site Number : 8400008 — Winston-Salem, North Carolina, United States
Asthma & Allergy Center - Toledo- Site Number : 8400110 — Toledo, Ohio, United States
Layrek Clinical Research- Site Number : 8400066 — Tulsa, Oklahoma, United States
The Oregon Clinic - Portland - Northwest 22nd Avenue- Site Number : 8400065 — Portland, Oregon, United States
Suburban Research Associates - Media- Site Number : 8400143 — Media, Pennsylvania, United States
MedTrial- Site Number : 8400010 — Columbia, South Carolina, United States
Chattanooga Research and Medicine- Site Number : 8400026 — Chattanooga, Tennessee, United States
Premier Research Center, Llc- Site Number : 8400146 — Hendersonville, Tennessee, United States
Solace Clinical Research- Site Number : 8400087 — Austin, Texas, United States
IntraCare- Site Number : 8400034 — Dallas, Texas, United States
Premier Pulmonary Critical Care and Sleep- Site Number : 8400111 — Denison, Texas, United States
El Paso Pulmonary Association- Site Number : 8400033 — El Paso, Texas, United States
Axsendo Clinical Research - Houston- Site Number : 8400054 — Houston, Texas, United States
Se Houston- Site Number : 8400120 — Houston, Texas, United States
Aavon Clinical Trials, Llc- Site Number : 8400166 — Houston, Texas, United States
Synergy Group US - Missouri City- Site Number : 8400119 — Missouri City, Texas, United States
Synergy Group US - Missouri City- Site Number : 8400133 — Missouri City, Texas, United States
Elligo Health Care, Hillcroft Medical Clinic Association- Site Number : 8400053 — Sugar Land, Texas, United States
Medrasa Clinical Research - Wylie- Site Number : 8400124 — Wylie, Texas, United States
Rheumatology & Pulmonary Clinic- Site Number : 8400012 — Beckley, West Virginia, United States
Investigational Site Number : 0320011 — Berazategui, Buenos Aires, Argentina
Investigational Site Number : 0320004 — Buenos Aires, Argentina
Investigational Site Number : 0320002 — Buenos Aires, Argentina
Investigational Site Number : 0320005 — Buenos Aires, Argentina
Investigational Site Number : 0320003 — Buenos Aires, Argentina
Investigational Site Number : 0320006 — Buenos Aires, Argentina
Investigational Site Number : 0320001 — Buenos Aires, Argentina
Investigational Site Number : 0320012 — Buenos Aires, Argentina
Investigational Site Number : 0320009 — Córdoba, Argentina
Investigational Site Number : 0320007 — Mendoza, Argentina
Investigational Site Number : 0320008 — Mendoza, Argentina
Investigational Site Number : 0320010 — Santa Fe, Argentina
Investigational Site Number : 0360007 — Coffs Harbour, New South Wales, Australia
Investigational Site Number : 0360008 — Tiwi, Northern Territory, Australia
Investigational Site Number : 0360006 — South Brisbane, Queensland, Australia
Investigational Site Number : 0360004 — Townsville, Queensland, Australia
Investigational Site Number : 0360002 — Traralgon, Victoria, Australia
Investigational Site Number : 0360001 — Osborne Park, Western Australia, Australia
Investigational Site Number : 5540004 — Dunedin, Australia
Universidade Federal de Goias- Site Number : 0760002 — Goiânia, Goiás, Brazil
Santa Casa de Misericordia de Belo Horizonte- Site Number : 0760004 — Belo Horizonte, Minas Gerais, Brazil
WM Pesquisas Clínicas em Doenças Respiratórias- Site Number : 0760003 — Porto Alegre, Rio Grande do Sul, Brazil
CEMEC - Centro Multidisciplinar de Estudos Clínicos - São Bernardo do Campo- Site Number : 0760001 — São Bernardo do Campo, São Paulo, Brazil
IBCC - Núcleo de Pesquisa e Ensino- Site Number : 0760005 — São Paulo, Brazil
Investigational Site Number : 1240051 — Kelowna, British Columbia, Canada
Investigational Site Number : 1240052 — West Vancouver, British Columbia, Canada
Investigational Site Number : 1240045 — Niagara Falls, Ontario, Canada
Investigational Site Number : 1240041 — Windsor, Ontario, Canada
Investigational Site Number : 1240049 — Longueuil, Quebec, Canada
Investigational Site Number : 1240055 — Montreal, Quebec, Canada
Investigational Site Number : 1240047 — Québec, Quebec, Canada
Investigational Site Number : 1240053 — Québec, Quebec, Canada
Investigational Site Number : 1240050 — Saint-Charles-Borromée, Quebec, Canada
Investigational Site Number : 1240054 — Saint-Charles-Borromée, Quebec, Canada
Investigational Site Number : 1240048 — Trois-Rivières, Quebec, Canada
Investigational Site Number : 1240042 — Victoriaville, Quebec, Canada
Investigational Site Number : 1520006 — Temuco, La Araucanía, Chile
Investigational Site Number : 1520004 — Recoleta, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520001 — Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520002 — Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520009 — Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520003 — Viña del Mar, Valparaiso, Chile
Investigational Site Number : 1520007 — Chillan, Chile
Investigational Site Number : 1560003 — Baotou, China
Investigational Site Number : 1560022 — Beijing, China
Investigational Site Number : 1560001 — Beijing, China
Investigational Site Number : 1560023 — Beijing, China
Investigational Site Number : 1560005 — Beijing, China
Investigational Site Number : 1560062 — Changchun, China
Investigational Site Number : 1560090 — Changde, China
Investigational Site Number : 1560057 — Changsha, China
Investigational Site Number : 1560052 — Chengdu, China
Investigational Site Number : 1560032 — Chengdu, China
Investigational Site Number : 1560037 — Chongqing, China
Investigational Site Number : 1560074 — Chongqing, China
Investigational Site Number : 1560078 — Dalian, China
Investigational Site Number : 1560051 — Foshan, China
Investigational Site Number : 1560042 — Ganzhou, China
Investigational Site Number : 1560015 — Guangzhou, China
Investigational Site Number : 1560034 — Guangzhou, China
Investigational Site Number : 1560038 — Guiyang, China
Investigational Site Number : 1560016 — Haikou, China
Investigational Site Number : 1560009 — Hangzhou, China
Investigational Site Number : 1560066 — Hangzhou, China
Investigational Site Number : 1560054 — Hebei, China
Investigational Site Number : 1560059 — Hefei, China
Investigational Site Number : 1560007 — Hohhot, China
Investigational Site Number : 1560050 — Honghehanizu, China
Investigational Site Number : 1560046 — Huai'an, China
Investigational Site Number : 1560004 — Huizhou, China
Investigational Site Number : 1560021 — Huzhou, China
Investigational Site Number : 1560065 — Jiangyin, China
Investigational Site Number : 1560081 — Jiaxing, China
Investigational Site Number : 1560055 — Jinan, China
Investigational Site Number : 1560028 — Jinan, China
Investigational Site Number : 1560013 — Jinan, China
Investigational Site Number : 1560079 — Jingzhou, China
Investigational Site Number : 1560040 — Jining, China
Investigational Site Number : 1560061 — Kunming, China
Investigational Site Number : 1560091 — Lanzhou, China
Investigational Site Number : 1560077 — Luoyang, China
Investigational Site Number : 1560063 — Meihekou, China
Investigational Site Number : 1560014 — Nanchang, China
Investigational Site Number : 1560087 — Nanchang, China
Investigational Site Number : 1560047 — Nanjing, China
Investigational Site Number : 1560082 — Nanjing, China
Investigational Site Number : 1560027 — Nanning, China
Investigational Site Number : 1560018 — Nanyang, China
Investigational Site Number : 1560073 — Panjin, China
Investigational Site Number : 1560029 — Qingdao, China
Investigational Site Number : 1560043 — Qingyuan, China
Investigational Site Number : 1560025 — Qinhuangdao, China
Investigational Site Number : 1560031 — Qiqihar, China
Investigational Site Number : 1560045 — Quzhou, China
Investigational Site Number : 1560008 — Shanghai, China
Investigational Site Number : 1560017 — Shanghai, China
Investigational Site Number : 1560072 — Shaoyang, China
Investigational Site Number : 1560035 — Shenyang, China
Investigational Site Number : 1560053 — Shijiazhuang, China
Investigational Site Number : 1560002 — Suzhou, China
Investigational Site Number : 1560024 — Taiyuan, China
Investigational Site Number : 1560030 — Tianjin, China
Investigational Site Number : 1560075 — Ürümqi, China
Investigational Site Number : 1560033 — Weifang, China
Investigational Site Number : 1560036 — Wenzhou, China
Investigational Site Number : 1560019 — Wuhan, China
Investigational Site Number : 1560071 — Wuhan, China
Investigational Site Number : 1560070 — Xi'an, China
Investigational Site Number : 1560020 — Xi'an, China
Investigational Site Number : 1560083 — Xiangyang, China
Investigational Site Number : 1560006 — Xinxiang, China
Investigational Site Number : 1560058 — Xuzhou, China
Investigational Site Number : 1560089 — Yinchuan, China
Investigational Site Number : 1560076 — Yiyang, China
Investigational Site Number : 1560044 — Zhangzhou, China
Investigational Site Number : 1560011 — Zhengzhou, China
Investigational Site Number : 1560084 — Zigong, China
Investigational Site Number : 1560039 — Zunyi, China
Investigational Site Number : 2030007 — Brandýs nad Labem-Stará Boleslav, Czechia
Investigational Site Number : 2030006 — Havlíčkův Brod, Czechia
Investigational Site Number : 2030005 — Hradec Králové, Czechia
Investigational Site Number : 2030001 — Jindřichův Hradec, Czechia
Investigational Site Number : 2030002 — Kralupy nad Vltavou, Czechia
Investigational Site Number : 2030004 — Prague, Czechia
Investigational Site Number : 2760005 — Bamberg, Germany
Investigational Site Number : 2760006 — Berlin, Germany
Investigational Site Number : 2760012 — Berlin, Germany
Investigational Site Number : 2760004 — Berlin, Germany
Investigational Site Number : 2760003 — Berlin, Germany
Investigational Site Number : 2760011 — Berlin, Germany
Investigational Site Number : 2760015 — Bonn, Germany
Investigational Site Number : 2760016 — Landsberg am Lech, Germany
Investigational Site Number : 2760002 — Leipzig, Germany
Investigational Site Number : 2760001 — Peine, Germany
Investigational Site Number : 2760010 — Witten, Germany
Investigational Site Number : 3000007 — Athens, Greece
Investigational Site Number : 3000006 — Athens, Greece
Investigational Site Number : 3000002 — Exochi, Greece
Investigational Site Number : 3000001 — Ioannina, Greece
Investigational Site Number : 3000004 — Palaió Fáliro, Greece
Investigational Site Number : 3760004 — Ashkelon, Israel
Investigational Site Number : 3760007 — Beersheba, Israel
Investigational Site Number : 3760010 — Haifa, Israel
Investigational Site Number : 3760008 — Haifa, Israel
Investigational Site Number : 3760005 — Jerusalem, Israel
Investigational Site Number : 3760003 — Jerusalem, Israel
Investigational Site Number : 3760002 — Petah Tikva, Israel
Investigational Site Number : 3760011 — Ramat Gan, Israel
Investigational Site Number : 3760001 — Rehovot, Israel
Investigational Site Number : 3760006 — Tel Aviv, Israel
Investigational Site Number : 4400001 — Kaunas, Lithuania
Investigational Site Number : 4580004 — George Town, Malaysia
Investigational Site Number : 4580006 — Kajang, Malaysia
Investigational Site Number : 4580003 — Kota Bharu, Malaysia
Investigational Site Number : 4580001 — Kuala Lumpur, Malaysia
Investigational Site Number : 4580002 — Kuala Terengganu, Malaysia
Investigational Site Number : 4580005 — Miri, Malaysia
Investigational Site Number : 4580007 — Sibu, Malaysia
Investigational Site Number : 4840012 — León, Guanajuato, Mexico
Investigational Site Number : 4840002 — Guadalajara, Jalisco, Mexico
Investigational Site Number : 4840009 — Chihuahua City, Mexico
Investigational Site Number : 4840010 — Durango, Mexico
Investigational Site Number : 4840003 — Mexico City, Mexico
Investigational Site Number : 4840016 — Mexico City, Mexico
Investigational Site Number : 5280002 — Arnhem, Netherlands
Investigational Site Number : 5280001 — Breda, Netherlands
Investigational Site Number : 5280010 — Dordrecht, Netherlands
Investigational Site Number : 5280007 — Nijmegen, Netherlands
Investigational Site Number : 5280008 — Nijmegen, Netherlands
Investigational Site Number : 5280003 — The Hague, Netherlands
Investigational Site Number : 5280009 — Zutphen, Netherlands
Investigational Site Number : 5540003 — Christchurch, Canterbury, New Zealand
Investigational Site Number : 5540002 — Ebdentown, Wellington Region, New Zealand
Investigational Site Number : 5540001 — Auckland, New Zealand
Investigational Site Number : 5780004 — Arendal, Norway
Investigational Site Number : 5780003 — Bergen, Norway
Investigational Site Number : 5780002 — Lørenskog, Norway
Investigational Site Number : 5780001 — Trondheim, Norway
Investigational Site Number : 6160005 — Poznan, Greater Poland Voivodeship, Poland
Investigational Site Number : 6160002 — Poznan, Greater Poland Voivodeship, Poland
Investigational Site Number : 6160007 — Krakow, Lesser Poland Voivodeship, Poland
Investigational Site Number : 6160004 — Lodz, Lódzkie, Poland
Investigational Site Number : 6160003 — Bialystok, Podlaskie Voivodeship, Poland
Investigational Site Number : 6160006 — Chęciny, Poland
Investigational Site Number : 6160001 — Ostrowiec Świętokrzyski, Świętokrzyskie Voivodeship, Poland
Investigational Site Number : 6420001 — Brasov, Romania
Investigational Site Number : 6420003 — Cluj-Napoca, Romania
Investigational Site Number : 6420002 — Oradea, Romania
Investigational Site Number : 7020002 — Singapore, Singapore
Investigational Site Number : 7020001 — Singapore, Singapore
Investigational Site Number : 7030002 — Humenné, Slovakia
Investigational Site Number : 7030003 — Levice, Slovakia
Investigational Site Number : 7030001 — Spišská Nová Ves, Slovakia
Investigational Site Number : 7100011 — Benoni, South Africa
Investigational Site Number : 7100009 — Boksburg, South Africa
Investigational Site Number : 7100001 — Cape Town, South Africa
Investigational Site Number : 7100003 — Cape Town, South Africa
Investigational Site Number : 7100002 — Durban, South Africa
Investigational Site Number : 7100014 — Durban, South Africa
Investigational Site Number : 7100006 — Durban, South Africa
Investigational Site Number : 7100004 — Durban, South Africa
Investigational Site Number : 7100005 — Johannesburg, South Africa
Investigational Site Number : 7100013 — Krugersdorp, South Africa
Investigational Site Number : 7100012 — Pretoria, South Africa
Investigational Site Number : 7100007 — Pretoria, South Africa
Investigational Site Number : 7100010 — Welkom, South Africa
Investigational Site Number : 4100007 — Anyang-si, Gyeonggi-do, South Korea
Investigational Site Number : 4100005 — Daegu, Gyeongsangbuk-do, South Korea
Investigational Site Number : 4100003 — Jeonju, Jeollabuk-do, South Korea
Investigational Site Number : 4100004 — Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 4100002 — Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 4100001 — Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 4100006 — Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 7240003 — Zaragoza, Aragon, Spain
Investigational Site Number : 7240001 — Badalona, Barcelona [Barcelona], Spain
Investigational Site Number : 7240004 — Santander, Cantabria, Spain
Investigational Site Number : 7240008 — Barcelona, Catalunya [Cataluña], Spain
Investigational Site Number : 7240007 — Madrid, Madrid, Comunidad de, Spain
Investigational Site Number : 7240006 — Madrid, Madrid, Comunidad de, Spain
Investigational Site Number : 7240002 — Madrid, Spain
Investigational Site Number : 7240005 — Madrid, Spain
Investigational Site Number : 1580007 — Changhua, Taiwan
Investigational Site Number : 1580008 — Hsinchu, Taiwan
Investigational Site Number : 1580001 — Kaohsiung City, Taiwan
Investigational Site Number : 1580004 — Taichung, Taiwan
Investigational Site Number : 1580005 — Taipei, Taiwan
Investigational Site Number : 1580002 — Taipei, Taiwan
Investigational Site Number : 1580003 — Taipei, Taiwan
Investigational Site Number : 1580006 — Taoyuan City, Taiwan
Investigational Site Number : 8260035 — Milton Keynes, Buckinghamshire, United Kingdom
Investigational Site Number : 8260007 — London, England, United Kingdom
Investigational Site Number : 8260008 — London, Hammersmith and Fulham, United Kingdom
Investigational Site Number : 8260006 — Southampton, Hampshire, United Kingdom
Investigational Site Number : 8260001 — London, London, City of, United Kingdom
Investigational Site Number : 8260016 — London, London, City of, United Kingdom
Investigational Site Number : 8260030 — Salford, Manchester, United Kingdom
Investigational Site Number : 8260013 — Chertsey, Surrey, United Kingdom
Investigational Site Number : 8260005 — Reading, United Kingdom
Investigational Site Number : 8260017 — Rotherham, United Kingdom

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment